BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3482978)

  • 21. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
    Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
    Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Change in the topologic bond number of closed DNA loops during differentiation of mouse erythroleukemia cells].
    Glazer VM; Luchnik AN
    Dokl Akad Nauk SSSR; 1980; 250(5):1247-50. PubMed ID: 6929248
    [No Abstract]   [Full Text] [Related]  

  • 23. [Malignancy of Friend erythroleukemic cells in DBA/2 mice correlated with their level of fibronectin sensitivity].
    Benedetto A; Amici C; Djaczenko W; Zaniratti S; Buttò S; Elia G
    Ann Ist Super Sanita; 1982; 18(3):447-51. PubMed ID: 6964823
    [No Abstract]   [Full Text] [Related]  

  • 24. Friend leukemic mouse stem cell reversion to normal growth in irradiated hosts.
    Matioli G
    J Reticuloendothel Soc; 1973 Oct; 14(4):380-6. PubMed ID: 4148038
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive immunotherapy for mouse leukemias with antisera of "directed" specificity: synergism with the action of cyclophosphamide.
    Reif AE; Li RW; Robinson CM
    Cancer Treat Rep; 1977 Nov; 61(8):1499-508. PubMed ID: 922753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
    Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
    Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Collins JJ; Genovesi EV; Livnat D; Sanfilippo F
    Cancer Res; 1981 Jun; 41(6):2407-15. PubMed ID: 7016314
    [No Abstract]   [Full Text] [Related]  

  • 29. An attempt at immunotherapy of murine virus erythroleukemia.
    Patocka F; Libánský J
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(1):17-22. PubMed ID: 102689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modulation of erythroid differentiation induced by DMSO in Friend cells treated with interferon: a clonal analysis].
    Affabris E; Jemma C; Federico M; Rossi GB
    Ann Ist Super Sanita; 1982; 18(3):425-7. PubMed ID: 6198946
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70.
    Callahan RM; Marx PA; Marum WG; Wheelock EF
    J Immunol; 1980 Aug; 125(2):616-22. PubMed ID: 6930443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of gangliosides in interferon and cell membrane interaction].
    Antonelli G; Belardelli F; Santurbano B; Aliberti A; Rugghero V; D'Agnolo G; Rossi GB
    Ann Ist Super Sanita; 1982; 18(3):429-32. PubMed ID: 6198947
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of immune stimulators on viral leukemogenesis.
    Marx PA; Wheelock EF
    Ann N Y Acad Sci; 1976; 276():502-12. PubMed ID: 1071975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of concanavalin A on the cellular interaction of abrin and ricin].
    Sorrentino M; Amici C; Belardelli F; Delfini C; Oberholtzer G
    Ann Ist Super Sanita; 1982; 18(3):459-62. PubMed ID: 6964824
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
    Tapiero H; Fourcade A; Vaigot P; Farhi JJ
    Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA; Peace DJ; Klarnet JP; Kern DE; Greenberg PD; Cheever MA
    J Immunol; 1986 Dec; 137(11):3675-80. PubMed ID: 3491145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon and friend virus-induced leukemic cells: in vivo and in vitro interactions.
    Rossi GB; Matarese GP; Marchegiani M; Grappelli C
    Boll Ist Sieroter Milan; 1974; 53(4):538-42. PubMed ID: 4451582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.